"James F. Holland, Physician Who Helped Show Chemotherapy Could Treat Cancer, Dies At 92" - Harrison Smith
When James F. Holland, MD, began his medical career in the early 1950s, oncology scarcely existed as a discipline. Cancer was considered more or less incurable. By the time of his death at 92, Dr. Holland, professor of medicine, hematology, medical oncology and oncological sciences, and distinguished professor of neoplastic diseases at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, had helped orchestrate a sea change in medicine’s approach to cancer, leading large-scale research studies that successfully demonstrated the effectiveness of chemotherapy. Through a technique known as combination chemotherapy, in which multiple drugs are used in concert, he effectively cured one form of childhood leukemia and laid the groundwork for the treatment of countless other types of the disease, including lymphoma and colorectal, breast and lung cancer. Dr. Holland joined Mount Sinai in 1973 after spending a year in the Soviet Union as part of an oncology exchange program.
- James F. Holland, MD, Professor, Medicine, Hematology and Medical Oncology, Oncological Sciences, Distinguished Professor, Neoplastic Diseases, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Additional coverage:
Medscape
The New York Times

Mount Sinai Researchers Discover Why Some Colon Cancers Resist Treatment
Feb 12, 2025 View All Press Releases
Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy
Jan 06, 2025 View All Press Releases
Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race
Sep 29, 2023 View All Press Releases
New RNA-based Therapy Combats Melanoma in Mouse Models
Jul 27, 2023 View All Press Releases
New Lung Immuno-oncology Therapeutic Strategy Identified
Apr 20, 2023 View All Press Releases
Scientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer
Apr 18, 2023 View All Press Releases